Treatment of Friedreich Ataxia with Cognitive Dysfunction
Cognitive dysfunction is a recognised feature that can affect individuals living with Friedreich ataxia. Addressing it requires a deliberate, structured approach — one that extends to families and carers, not only the patient.
Clinical scenario: Friedreich ataxia in the setting of cognitive dysfunction — supporting patients, families, and carers in understanding and managing cognitive changes.
The evidence-based approach focuses on a targeted educational intervention for patients, their families, and carers — aimed at improving understanding of the potential for cognitive dysfunction and its management. The full protocol also includes specific guidance on which interventions are not recommended in this population. Details on implementation and the complete clinical recommendations are available in the structured protocol below.
References
DOI: 10.1186/s13023-022-02568-3
- We suggest development and implementation of an educational program for affected individuals and their families and carers to improve information about the potential for, and management of, cognitive dysfunction in individuals with Friedreich ataxia.
- We recommend that clinicians should not use active neuromodulation (tDCS, TMS) as part of clinical practice to improve cognitive function in individuals with Friedreich ataxia.
View source ↗